Historically AMR clinical research centers have enrolled more than 145,600 subjects in 7,750 clinical trials. AMR’s extensive experience includes phase I-IV healthy volunteer trials, device trials, and disease-specific trials across a wide range of therapeutic areas. In 2020, AMR was awarded multiple COVID-19 Investigational Vaccine Trials including one of the first two Phase I studies completed in the United States.
The following list summarizes AMR’s primary areas of expertise: